Biotech Crypto News
Biotech crypto news from Token Times: 2 original briefs, each synthesised from across 50+ outlets, cross-checked for agreement on the key figures, enriched with live market data and Bitcoin-timestamped for provenance. The latest Biotech developments are below — updated hourly, with the data context no single outlet carries.
Moderna's stock fell 17% despite positive Phase 3 trial results for its melanoma vaccine developed with Merck.
ImmunityBio's ANKTIVA shows strong efficacy in bladder cancer trials, yet the company's stock drops 7.25%.